Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.04% | $8.55M | €458.38B | 86.92% | 76 Outperform | |
| AstraZeneca | 2.16% | $6.08M | $305.49B | 27.65% | 80 Outperform | |
| Shell (UK) | 1.75% | $4.92M | £179.19B | 24.58% | 73 Outperform | |
| Siemens | 1.50% | $4.23M | €176.96B | 2.09% | 74 Outperform | |
| Nestlé SA | 1.45% | $4.08M | CHF201.30B | 0.07% | 71 Outperform | |
| Banco Santander | 1.44% | $4.06M | €146.91B | 62.23% | 73 Outperform | |
| Roche Holding AG | 1.38% | $3.89M | CHF268.16B | 29.32% | 73 Outperform | |
| HSBC Holdings | 1.35% | $3.80M | £219.84B | 52.09% | 80 Outperform | |
| Novartis AG | 1.34% | $3.77M | CHF232.19B | 30.93% | 80 Outperform | |
| SAFRAN SA | 1.33% | $3.75M | €133.83B | 28.93% | 67 Neutral |